A method of inhibiting a histone deacetylase activity, comprising administering to a recipient subject in need thereof a composition that contains an effective amount of small somatic stem cells that are greater than 2 micrometers and less than 6 micrometers in size, wherein the small somatic stem cells include CD349+ somatic stem cells and Lgr5+ somatic stems cells.
